Azora Therapeutics, Inc.

AZR Healthcare Biotechnology

EPS
−150.0%
Free cash flow
−263.7%

Quarter to June 2026, against a year earlier

3.82 0.23 −5.68%
Market cap
$9.7M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments
28.71 4.58 5.88 4.61

+8 more quarters

Total current assets
28.85 4.80 6.18 5.01
Long-Term Investments
0.24 0.42 0.49 0.64
Goodwill and Intangible Assets (Total)
0.00 0.00 0.00 0.00
Total non-current assets
0.24 0.42 0.49 0.65
Total Assets
29.09 5.23 6.67 5.66
Accounts Payable
2.62 0.57 0.66 0.56
Accrued Expenses
2.50 0.94 0.74 0.60
Total current liabilities
5.12 1.51 1.40 1.15
Liabilities (Preferred Stock)
38.53 — — —
Non-current Liabilities (Other)
23.81 — — —
Total non-current liabilities
62.35 — — —
Total liabilities
67.47 1.51 1.40 1.15
Additional Paid In Capital
105.60 95.71 95.25 92.46
Common Stock (Net)
0.00 0.00 0.00 0.02
Retained Earnings
(143.98) (91.99) (89.97) (87.98)
Common Equity (Total)
(38.38) 3.72 5.28 4.51
Shareholders Equity (Total)
(38.38) 3.72 5.28 4.51
Shareholders Equity and Liabilities (Total)
29.09 5.23 6.67 5.66
Shares (Common)
2.63 1.51 1.11 0.95
Shareholders Equity (Tangible)
(38.38) 3.71 5.27 4.50
Net Debt
(28.71) (4.58) (5.88) (4.61)

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 26 Oct 2026